1. Home
  2. PBBK vs ITRM Comparison

PBBK vs ITRM Comparison

Compare PBBK & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBBK
  • ITRM
  • Stock Information
  • Founded
  • PBBK 1919
  • ITRM 2015
  • Country
  • PBBK United States
  • ITRM Ireland
  • Employees
  • PBBK N/A
  • ITRM N/A
  • Industry
  • PBBK Banks
  • ITRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBBK Finance
  • ITRM Health Care
  • Exchange
  • PBBK Nasdaq
  • ITRM Nasdaq
  • Market Cap
  • PBBK 45.2M
  • ITRM 40.0M
  • IPO Year
  • PBBK N/A
  • ITRM 2018
  • Fundamental
  • Price
  • PBBK $18.02
  • ITRM $1.00
  • Analyst Decision
  • PBBK
  • ITRM Strong Buy
  • Analyst Count
  • PBBK 0
  • ITRM 2
  • Target Price
  • PBBK N/A
  • ITRM $7.00
  • AVG Volume (30 Days)
  • PBBK 4.6K
  • ITRM 478.2K
  • Earning Date
  • PBBK 08-13-2025
  • ITRM 08-13-2025
  • Dividend Yield
  • PBBK N/A
  • ITRM N/A
  • EPS Growth
  • PBBK 12.16
  • ITRM N/A
  • EPS
  • PBBK 0.83
  • ITRM N/A
  • Revenue
  • PBBK $12,804,000.00
  • ITRM N/A
  • Revenue This Year
  • PBBK N/A
  • ITRM N/A
  • Revenue Next Year
  • PBBK N/A
  • ITRM $270.19
  • P/E Ratio
  • PBBK $22.57
  • ITRM N/A
  • Revenue Growth
  • PBBK 5.21
  • ITRM N/A
  • 52 Week Low
  • PBBK $13.85
  • ITRM $0.81
  • 52 Week High
  • PBBK $19.05
  • ITRM $3.02
  • Technical
  • Relative Strength Index (RSI)
  • PBBK 66.45
  • ITRM 48.91
  • Support Level
  • PBBK $16.49
  • ITRM $0.93
  • Resistance Level
  • PBBK $19.05
  • ITRM $1.06
  • Average True Range (ATR)
  • PBBK 0.59
  • ITRM 0.05
  • MACD
  • PBBK 0.14
  • ITRM 0.01
  • Stochastic Oscillator
  • PBBK 91.23
  • ITRM 28.26

About PBBK PB Bankshares Inc.

PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: